Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Migraineguard ™ Supplement Reduces the Severity and Frequency of Migraine , a Randomized, Placebo-controlled, Double-blind, Trial

NCT04759040 is registered in ClinicalTrials.gov with Herbacure Natural as lead sponsor.

NCT NCT04759040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04759040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Migraineguard ™ Supplement Reduces the Severity and Frequency of Migraine , a Randomized, Placebo-controlled, Double-blind, Trial
Lead sponsor
Herbacure Natural
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2020
Completion date
November 25, 2020
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

headache, migraine